Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Once upon a prime: DCs shape cancer immunity
Maria Zagorulya, Stefani Spranger
Trends in cancer (2022) Vol. 9, Iss. 2, pp. 172-184
Closed Access | Times Cited: 23

Showing 23 citing articles:

Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer
Maria Zagorulya, Leon Yim, Duncan M. Morgan, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 386-405.e10
Open Access | Times Cited: 81
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 5
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy
Ali Ghasemi, Amaia Martinez‐Usatorre, L. Li, et al.
Nature Cancer (2023) Vol. 5, Iss. 2, pp. 240-261
Open Access | Times Cited: 21
Progresses in biomarkers for cancer immunotherapy
Xuwen Lin, Chenyu Zong, Zhihan Zhang, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 18
The tumor-draining lymph node as a reservoir for systemic immune surveillance
Ines Delclaux, Katherine S. Ventre, Dennis Jones, et al.
Trends in cancer (2023) Vol. 10, Iss. 1, pp. 28-37
Open Access | Times Cited: 17
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Yanyan Zheng, Jiawei Wang, Guangya Zhao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010521-e010521
Open Access
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access
Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity
Taral R. Lunavat, Lisa Nieland, Sanne M. van de Looij, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Yun Feng, Qinglai Tang, Bin Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
EUS-guided radiofrequency ablation for pancreatic adenocarcinoma
Curtis J. Wray, Baylee J. O’Brien, Putao Cen, et al.
Gastrointestinal Endoscopy (2024) Vol. 100, Iss. 4, pp. 759-766
Open Access | Times Cited: 2
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 2
Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
Rayansh Poojary, Andy Song, Benny Shone Song, et al.
Molecular and Clinical Oncology (2023) Vol. 19, Iss. 6
Open Access | Times Cited: 4
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapy
Zheng-Yu Qian, Yi‐Qian Pan, Xuexin Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 6, pp. 803-822
Open Access | Times Cited: 1
Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer
Michihisa Kono, Shin Saito, Masahiro Rokugo, et al.
Oral Oncology (2024) Vol. 152, pp. 106795-106795
Closed Access | Times Cited: 1
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Qiannan Gu, Anning Qi, Ne Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113137-113137
Closed Access | Times Cited: 1
Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy
Abdullah M. Shbeer
Pathology - Research and Practice (2023) Vol. 253, pp. 155025-155025
Closed Access | Times Cited: 2
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Sergio Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 2
Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung Adenocarcinoma
Hilal Özakıncı, Xiaofei Song, Gina S. Nazario, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 7, pp. 1033-1041
Open Access
Janus-faced role of neutrophils in cancer
Tanya N. Mayadas, Hongbo R. Luo
Elsevier eBooks (2024)
Closed Access
Amphiphile-engineered DNA adjuvants stimulate strong type I IFN production in lymph nodes via cytosolic danger-sensing to induce potent cellular and humoral immunity in mice and non-human primates
Martin P. Steinbuck, Lochana M. Seenappa, Wei Zhan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CITMIC: Comprehensive Estimation of Cell Infiltration in Tumor Microenvironment based on Individualized Intercellular Crosstalk
Xilong Zhao, Jiashuo Wu, Jiyin Lai, et al.
Advanced Science (2024)
Open Access
Magnesium enhances the graft‐versus‐tumor effect of donor lymphocytic infusion on hematologic malignancies
Yan Wei, Jiayuan Guo, Ning Lü, et al.
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 922-932
Open Access
Page 1

Scroll to top